posit transform long-term valuat
reflect upsid integr initi neutral
integra lifesci multi-seg medic technolog compani
offer regen technolog specialti surgic solut
orthoped product address wide array condit collect
integra grown organ product develop
acquisit target organ growth long-term
believ compani possess strong product offer matur
higher growth market allow reach long-term growth
goal near-term believ premium valuat reflect investor
sentiment codman neuro acquisit integr go well
given management caution see opportun time
integr risk tabl growth acceler initi neutral
sale forc expans creat deeper channel penetr
recent codman acquisit iart sale forc grow
level expand sale forc provid foothold
countri previous minor presenc also creat
cross-sel opportun expand product portfolio
acquisit may take rep field longer period
may prove conserv abl integr
faster take cautiou stanc integr take longer
estim believ could still channel disrupt
add back-end support convert manufactur believ
result higher growth organ growth guid
long-term expect margin expans strong
view revenue scale codman integr
abl drive margin gm leverag
debt paid also expect healthi ensu
valuat integra rate neutral risk discuss
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
integra product offer address varieti medic technolog market
opportun higher growth secular tailwind
extrem orthoped wound reconstruct other
matur precis instrument tool neuromonitor
cerebral-spin fluid manag collect integra built multi-
segment medic technolog compani grow toward long-term
goal revenu adj ebitda margin grow
organ revenu consist ep growth annual believ
time integra achiev target requir addit
acquisit reach revenu mileston growth select
product categori regen technolog help lift margin
well intern portfolio optim manufactur
near-term bit cautiou share given current expect
guidanc organ growth low end integra
long-term growth rang guidanc organ
growth per management lower growth guidanc combin premium
valuat reflect investor belief integr go smoothli
littl disrupt slower growth near-term result
recent codman neuro acquisit began impact integra
grew lsd pro-forma basi integra
expect sale disrupt peopl field longer normal
may spill impact
integr complet said view integra compani
posit transform long-term improv organ inorgan
growth profil integr complet stori could becom
interest investor believ collect integr yield
cross-sel opportun expand sale forc significantli give
integra signific footprint higher growth intern market
combin faster product introduct cadenc
conjunct cautiou tone also view
valuat fair leav limit room upsid reflect investor
posit view integr success management guidanc may
prove conserv integra histor trade ntm ep basi
one standard deviat ntm ep
ntm ep past three year respect look valuat
past year integra fare better trade averag ntm
ep standard deviat ntm ep
ntm ep respect integra current valuat
estim ntm ep believ valuat reflect improv outcom
leav limit upsid share today
initi neutral due near-term risk valuat
would expect may better opportun step new
investor add exist posit compani codman
acquisit largest integra histori rear-view mirror assum
integr timelin remain track
combin integra codman becom neurosurg
powerhous market
februari integra acquir codman neurosurg carv
johnson johnson sell pt analyst dane leon prior
acquisit integra well-known larg player
neurosurg market varieti product serv multipl area
treatment neurosurg condit codman acquisit
integra took neurosurg product offer significantli stronger
posit view even growth mani market lsd
msd addit integra compet codman varieti year
specif sub-seg neurosurgeri acquisit remov one
integra largest neurosurg competitor said combin portfolio
legaci integra legaci codman littl specif overlap ad key
product integra includ programm valv shunt anti-microbi
cathet integra previous didnt offer addit codman
intern revenu mix associ sale infrastructur allow integra
enter market size scale would taken year build
organ fulli integr expect
resourc necessari support codman put place expect
next month believ combin busi comprehens
forerunn neurosurgeri estim sale combin
sale forc expect grow rep abl cross sell
product leverag codman brand introduc varieti product
countri legaci integra previous sizabl presenc
expect product introduct new countri product registr
describ support higher growth level impact
late
overal integra sale forc grow fte
much growth come codman rep us
ou nonetheless combin result busi creat
opportun specif market cross-sel deeper channel
penetr view segment increas sale rep
follow
codman specialti surgic css rep total grow rep
orthoped tissu technolog ott rep total grow
follow acquisit integra also reorgan sale forc
distinct sale channel better address custom call point within
codman special surgic specialist rep address distinct area
essenti align along neurosurg channel largest neuro sale
forc compani compet sector
figur codman specialti surgic address wide array neurosurg area
within ott rep align sale channel greater physician
specialti variat amongst ott segment specif extrem
orthoped rep call orthoped surgeon wound reconstruct
rep call varieti physician treat wound care inpati
outpati clinic set lastli surgic reconstruct rep
distributor typic call gener surgeon plastic surgeon
oper specialti may util surgimend amniot
overal increas rep result codman acquisit
expect hire ramp ott particularli import integra
intern expans compani ad intern resourc
china japan alon doubl sale footprint tripl
revenu two larg market european sale infrastructur
increas acquisit well believ increas sale
forc combin focus strategi intern product expans
regulatori approv help energ intern sale forc
said see increas intern sale momentum occur late
integr codman becom settl year
grow proport regen medicin product
combin sku ration manufactur
optim lift time
integra acquisit derma scienc
help transform compani grow regen medicin
toward long-term goal total compani revenu import
note integra defin regen medicin product across
revenu categori codman specialti surgic orthoped tissu
technolog expect tissu technolog specif grow toward
total compani revenu primarili collagen amniot
synthet tissu product laid integra recent decemb
analyst day said quit exit
point model total compani revenu come regen
technolog note derma scienc came ahead expect
guidanc certainli help left regen medicin
toward total compani revenu believ also creat
challeng comparison addit integra offer varieti
collagen base wound care product believ see slower growth
rel higher growth amniot skin substitut slower growth
collagen base wound dress keep us slightli integra
importantli mani product within regen medicin carri
accret compani overal adj gm proport
regen product continu grow time expect
margin expans multipl year increas presenc
product expect integra may need elimin lower margin sku
came derma scienc acquisit area basic wound
separ expect integra also reduc lower margin product beyond
wound care carri dilut margin rel integra corpor averag
expect improv portfolio sku optim yield
gm lift time lastli expect improv
manufactur help lift time much
codman manufactur transit integra year process
long-term integra gm goal expect highlight
expect ramp model combin adjust om
adjust ebitda
figur expect ramp gm adj om adj ebitda
ebitda margingross margingross marginnon-gaap oper marginadjust ebitda
product expans bolster growth
integra intern presenc averag total compani sale
past year codman acquisit expect product
introduct cadenc non-codman product cusa clariti primarili
forth-com expect intern sale
increas total compani sale outlin integra
recent analyst day sale could increas even higher
beyond new product introduct codman acquisit give integra
sizabl sale presenc larg intern market china japan
codman alon add sale rep intern highlight
integra expect product cadenc key intern market specif
expect cusa clariti signific driver intern sale growth
addit product registr variou countri integra
market develop activ key market educ
event specif area neuro trauma hydrocephalu icp monitor
regen technolog extrem orthoped model increas
intern revenu consist guidanc maintain
similar level
figur integra us/ou actual expect revenu split
total ankl arthroplasti product portfolio right place
right time
integra total ankl arthroplasti product portfolio compris two key
product compani cadenc total ankl system salto
talari ankl origin tornier part wright medic
rate cadenc releas earli salto talari acquir
tornier collect integra total ankl product grown well
past quarter growth y/i
double-digit per management commentari expect growth well
beyond integra corpor averag market compound-annual-growth-rate
lower extrem estim total ankl arthroplasti
taa grow even faster small base procedur driven
robust patient demand favor reimburs chang occur
late discuss reimburs section analysi
overal number still low remain small
believ growth overal revenu dollar could becom meaning
revenu base grow addit integra gain ou right
salto talari ankl end improv growth key
difficult estim total number total ankl procedur
perform us today key metric first note figur
show increas incid taa procedur us per
singh et al estim patient underw
procedur
figur incid total ankl arthroplasti us
singh et al journal clinic rheumatolog
valid estim singh et al studi data queri
agenc healthcar research qualiti show similar result
ran procedur hospit inpati nation statist databas
procedur code total ankl replac replac
foot toe revis replac lower
extrem result follow
procedur estim slightli higher singh et al may
result classif definit variat exit find
total ankl arthroplasti procedur base ahrq
databas believ number risen substanti sinc
reimburs rate procedur gone product
avail physician increas well expect integra continu
capit burgeon area orthoped complet product
portfolio competit orthoped player
overal wound care market dynam encourag
overal wound care market signific estim
world-wide includ item tradit dress gauz bandag
well advanc product neg pressur wound therapi
algin foam hydrogel biolog etc within broader wound care
market advanc wound care market estim market
specif compris sever product categori includ advanc
number rate discharg per
therapi biolog demand advanc wound care product
driven number factor includ increas incid diabet
chronic condit rise demand innov
wound manag product due dynam advanc wound
care market expect grow compound-annual-growth-rate integra
product portfolio address multipl segment larg market
higher growth area advanc wound care market biolog
estim ww market within biolog skin
substitut integra primatrix well advanc product
amniot repres market today skin substitut market
project grow compound-annual-growth-rate reach
patient difficult heal wound util product
addit skin substitut market remain under-penetrated base
amount wound requir heal rel receiv medic care
within us market today specif note estim wound
requir medic care within us difficult heal use
convent therapi stand today patient
treat skin substitut year everi patient would qualifi
skin substitut believ opportun increas usag
product
figur estim market growth wound care product categori
lastli note variou physician call integra well regard
amongst physician treat wound overarch theme amongst
variou wound care physician integra offer full array product
treat varieti wound physician appreci integra end-to-end
solut wound treatment note integra offer varieti wound
care product particularli orient toward outpati wound clinic
includ medihoney wound prepar amniot primatrix
omnigraft wound treatment tcc-ez wound heal among
variou product
codman grew lsd pro-forma basi integra
intend acceler busi transitori period
believ risk
midway integra long-term organ growth target
codman acquisit integra growth outlook reduc
follow result busi mix shift overal
compani specif codman longer term growth expect call
growth lower legaci integra codman
revenu sizabl enough shift overal growth rate codman end
lsd pro-forma basi bottom end legaci rang
believ lsd result partial driven johnson johnson under-
invest codman asset expect improv given
integra focu space
note though codman benefit integra numer way also
particip matur market similar legaci integra
neuromonitor csf manag lower end
integra codman expect growth guidanc constrain
codman abil acceler management guid linear increas overal
organ revenu growth quarter quarter basi result
integr effort creat opportun longer-
term note integra complet signific step
codman integr includ realign territori amongst sale rep
revis incent structur codman rep said still
believ risk integr caution unforeseen disrupt
due fact codman one compon johnson johnson
integra acquir codman codman come full infrastructur
support compani integra must build function state
may take year believ primarili within
intern portion codman busi logist custom servic
etc may constrain factor growth year
also cautiou sale forc doubl product portfolio could
also overwhelm way integra management intend stagger
new product introduct overwhelm
sale forc even immedi impact product portfolio
nearli size could challeng rep css segment see
dynam risk growth particularli
keep mind go
integr largest acquisit
compani histori first half
expect
disrupt base busi
includ organ busi
would expect limit
term organ growth especi
first half year versu second
half
compound slower growth exist franchis
integra exit adjust organ growth rang bp
previou expect codman primarili drove adjust
believ franchis segment may grow slower well specif
refer dural repair midway management expect dural
repair msd grower specif result
y/i expect moder lsd interestingli
integra legaci dural repair busi rebound result growth
enter integra expect busi flat
integr codman underway
dural repair market seen signific competit price pressur
result integra sign long-term contract
maintain share believ result lower per unit price dural
repair product expect quarter quarter stabil
inclus long-term contract note lower price growth
may somewhat mute model y/i growth legaci dural repair
integr underway although expect growth rate
steadili improv quarter quarter basi
sale disrupt expect due integr
management reiter sale disrupt relat core busi
result expect loss busi result sale peopl
field longer normal time period extens
product train integra integr codman
organ convers management note rep
primarili field januari februari go train
expand css product portfolio march css team back
field sell addit note senior leadership codman
larg retain follow acquisit minim disrupt senior
leadership went countri countri visit codman rep
employe insur commit busi minim
given guidanc y/i organ know management
set expect order beat cautiou near-term
integr complet disrupt could sizabl impact
integra busi could impact result rest year
know franchis impact
integr assum integr magnitud
take time attent away core busi execut
expect call ebitda margin expans
 could delay plan
integra exit adjust ebitda margin year
cours management expect ebitda margin regress
codman integr integra enterpris integr
come leverag opportun expand ebitda margin
long-term end believ achiev
integra expand higher margin regen product portfolio also
streamlin integr codman acquisit look
integra expect adjust ebitda margin
combin gm improv
continu leverage/oper activ sale
figur ebitda margin expans time
without acquisit believ long-term goal potenti
achiev also believ order integra reach long-term
revenu goal compani may acquir addit asset compani
year practic compani time
like tuck-in acquisit integra fair amount
would impact ebitda margin integra layer product
portfolio strip away infrastructur
larger acquisit add new product call point infrastructur may
delay ebitda margin ramp integra long-term goal though mani
growth compani integra may acquir typic lower neg
ebitda margin note integra state compani number
goal reach revenu order compani achiev
integra need acquir asset
could see integra expect adjust ebitda margin goal push
slightli march toward revenu
integra acquisit strategi may lead addit cost
liabil
januari decemb integra acquir busi
believ order integra achiev long-term goal
sale acquisit essenti part management plan time integra
undertak acquisit risk addit cost higher
expect requir integr busi could associ
liabil may unforeseen anticip growth result
acquisit may materi
integra compet varieti market segment
may subject chang reimburs third parti
integra garner favor reimburs area total ankl
arthroplasti result materi improv outlook
lower extrem orthoped posit compani integra
compet varieti area may subject chang
reimburs often time neg may impact busi
time time third parti payer may reduc reimburs rate
choos pay procedur product believ one area integra
may particularli vulner within wound care tissu reconstruct
market signific believ third parti payer look
addit efficaci data product use within wound care may chang
reimburs rate time
integra signific debt oblig may divert
resourc away invest
decemb integra total debt integra current
leverag ratio requir lender requir compani
exceed leverag end integra intend reduc leverag
get end fiscal year
believ integra debt level manag feel prudent note
risk associ heighten debt level first quarterli instal
compani term loan due march matur date
remain decemb follow princip repay schedul
integra histor trade ntm ep basi one standard
deviat ntm ep ntm ep
past three year respect look past year
integra fare better trade averag ntm ep standard
deviat ntm ep ntm ep
respect integra current valuat estim ntm
ep believ valuat reflect improv outcom
leav limit upsid share today
integra rate neutral integra trade estim next
twelv month ep project versu comp group forecast
revenu compound-annual-growth-rate comp group
forecast ep compound-annual-growth-rate slightli
comp group feel discount overal comp group warrant
given integra histor trade rang slower expect top-lin growth
near-term risk associ acquisit btig publish
price target neutral rate stock
ntm scientificbsxbuy medicalgmedbuy surgicalisrgneutr medicalmmsinot medicalwmginot factset data btig research estim ex-amortev/salesev/ebitdacagrcompanytickerr ptpricemarket cap
quarterli earn quarterli earn biggest singl indic
integra success quarter integra provid detail commerci
progress trend compani profit believ key metric
integra revenu growth overal segment organ revenu growth
adjust gross margin adjust ebitda adjust ep
clinic confer numer confer investor
see compon integra product portfolio specif note upcom
confer includ american associ plastic surgeon aap
american burn associ aba intern societi
advanc spine surgeri isass symposium advanc wound
sawc american associ neurolog surgeon aan
american societi aesthet plastic surgeri asap american
orthopaed foot ankl societi aofa nation podiatr
acquisit integra acquisit past year purchas
numer product compani includ codman neuro derma scienc
well other addit integra acquir specif
product product line compani salto talari ankl
time integra make acquisit investor use event evalu
posit compani believ acquisit may help
support revenu growth potenti accret margin
ep often time smaller acquisit typic dilut integra overal
ebitda margin acquir compani earlier stage growth asset
believ import quarter investor critic
trade event management report whether integr codman
track well timelin sale disrupt occur beyond
integra expect share may pull back convers sale less
disrupt anticip due integr share may move higher
although believ integra premium valuat may alreadi account
integra oper varieti market higher growth area total
ankl arthroplasti mid-teen growth matur market tool
instrument low-singl digit growth collect integra posit
diversifi revenu base across multipl market one singl
market matur slow other may abl off-set
soft higher growth also expect certain market
regen medicin extrem orthoped within orthoped tissu
technolog favor demograph support higher growth
multipl year highlight market opportun
css busi segment exit address market
opportun collect
within precis tool instrument pti market opportun greater
overal market grow lsd specialti
instrument y/i growth gener surgeri
within dural access repair market opportun grow
msd importantli integra see addit opportun busi
line integra possess dural sealant spinal indic
addit larg proport neurosurgeon use dural graft
sealant close dura instead choos tri sow dura
waterproof seal integra see addit opportun grow market
educ gain physician support use dural graft sealant
oppos sutur clinic studi show failur rate sutur
within advanc energi market opportun grow
lsd msd growth primarili driven larg custom base
upgrad newer cusa system said recent codman
acquisit advanc energi franchis becam balanc
addit versutru codman bipolar forcep product offer
within neuro monitor market opportun grow in-
line broader neurosurg market like lsd major
busi driven codman intra-crani pressur monitor solut
signific portion growth come addit product
offer complement icp monitor directlink
lastli css cerebrospin fluid manag primarili codman
busi market opportun programm shunt
hakim valv well known treatment hydrocephalu
portfolio driven round product offer expect grow in-
line broader neurosurg market
extrem orthoped wound regener
within extrem fixat market opportun ankl
replac market grow mid-teen shoulder market
grow hsd market opportun attract due
low penetr rate high growth rate integra competit
offer ankl arthroplasti add pyro-carbon shoulder
futur help drive growth shoulder separ integra ad new
product fusion arthrodesi nail
within tissu technolog integra organ sale forc
advanc wound outpati surgic reconstruct across
segment market opportun divers array product
compris collagen amniot synthet wound care product
organ acquir tissu technolog market opportun
split surgic reconstruct wound
reconstruct acut advanc wound outpati
estim respect tissu technolog market grow
doubl digit address wound care opportun signific
integra lifesci multi-seg medic technolog compani offer
regen technolog specialti surgic solut orthoped
solut help surgeon limit uncertainti order provid best care
patient integra found engin collagen technolog
platform expand variou product line includ burn deep
tissu wound dura repair nerv tendon repair well area
integra grown past year build core
technolog acquir busi market overlap custom base
develop addit product meet custom need compani
headquart plainsboro new jersey employ sinc
grown revenu compound-annual-growth-rate
integra split two product categori codman specialti surgic
orthoped tissu technolog within two bucket varieti
franchis level busi discuss codman specialti
surgic compris major revenu recent codman
neurosurgeri acquisit prior acquisit codman specialti
surgic categori compris total revenu orthoped
tissu technolog compris management forese
dynam remain proport equival see mix shift
franchis unit within revenu bucket
figur integra oper segment franchis
codman specialti surgic offer varieti surgic instrument
broad rang specialti includ neurosurgeri critic care
busi base day day need neurosurgeon offer
product solut dural repair precis tool instrument tissu
ablat neuro critic care cerebrospin fluid csf instrument
segment bolster acquisit codman neurosurgeri
busi johnson johnson close franchis
segment collect combin revenu address market
opportun provid overview segment
associ revenu franchis
within codman specialti surgic segment varieti product
across continuum care neurosurgeri highlight key product
within entir revenu categori
cusa tissu ablat famili product cusa system ultrason
tissu ablat system offer surgeon tool debulk breakdown
fibrou tissu neurosurg procedur cusa system come
varieti option custom base advanc featur numer
hand piec depend extent fibrou tissu need
broken
duragen duragen onlay graft place dural tissu form
watertight seal prevent csf leak post-op integra offer varieti
size variat classic duragen product usag duragen
primarili seen cranial procedur duragen gain usag
spinal surgeri well
duras similar duragen duras dural sealant use
overlay convent sutur duras compos polyethylen
glycol ester solut trilsin amin solut combin
two product form sealant creat quick dri watertight seal
allow surgic site heal effect
light bright lumen surgic site follow
surgeon eye-path surgeri oppos overhead boom light
direct light improv visual critic anatomi headlight
power varieti light sourc light box luxtec
use conjunct headlight scope
surgic instrument integra offer varieti surgic instrument
line multipl specialti variou brand name includ integra
ent jarit microfr omni-tract ruggles-redmond instrument
steril reusabl surgic instrument come varieti
configur size time expect integra entir instrument
product line brand codman name brand well known
within industri
orthoped tissu technolog
orthoped tissu technolog compris soft tissu repair
product tissu regener product small bone fixat product joint
varieti product treat wound includ acut wound burn
chronic wound addit compani address surgic tissu repair
product hernia repair peripher nerv repair tendon repair
orthoped side integra extrem bone joint reconstruct product
includ hardwar bone joint fixat joint replac
devic implant instrument repair hand wrist elbow
shoulder foot ankl leg knee collect compon
ott address market opportun provid overview
franchis unit within ott segment well key product associ
figur orthoped tissu technolog segment franchis
omnigraft dermal regener matrix omnigraft indic use
treatment partial full-thick neuropath diabet foot ulcer
greater week durat omnigraft product approv
pma- fda follow clinic studi show omnigraft
increas wound closur multi-cent random control
parallel group studi conduct patient site
cadenc total ankl cadenc total ankl
design treat ankl arthriti replac ankl joint
prosthesi reduc pain restor align improv movement
joint design cadenc ankl allow surgeon keep bone
stock provid option align ankl back origin locat
design cadenc natur flexion/extens axi ankl
salto talari ankl fixed-bear devic whose rotat mobil
tibial compon self-align distal tibia determin talar
surgimend surgimend collagen matrix use across varieti
disciplin soft tissu repair reconstruct product deriv
bovin dermi come varieti size thick strength
depend clinic need
titan modular shoulder titan revers shoulder
titan shoulder system offer bone preserv option patient need
total hemi shoulder arthroplasti system allow surgeon select
distal stem proxim bodi match patient anatomi
within codman specialti surgic specif within us integra
product sold combin direct sale rep sale agent
distributor depend call point integra intern sale forc
special sale organ primarili call neuro-crit care unit
neurosurgeon separ integra sale rep call steril
process depart purchas instrument facil
recent codman acquisit integra ad sale rep
ou within us integra direct rep lastli integra also
sale rep call physician dental veterinari offic
instrument product applic area intern
integra sell direct distributor depend countri
direct certain european countri australia new zealand canada
within orthoped tissu technolog integra use combin
direct sale rep specialti distributor depend call point integra
team call surgeon treat wound extrem orthopaed
disord team dedic shoulder surgeon team dedic wound
care clinic respect physician team call surgeon
treat surgic tissu repair gener surgeon small group clinic
sale specialist focus regen product across multipl sale
channel outsid us integra direct select european countri
australia new zealand canada util distributor
much integra product portfolio exclus wound care fall
inpati prospect payment ipp commerci payer
medicar alik assign procedur specif reimburs base ms-drg
one specif product code integra would util garner
reimburs product ultim surgeon product
user hospit custom said chang reimburs
significantli impact util saw total ankl replac
total ankl replac reassign ms-drg ms-
drg result chang increas total ankl reimburs
hospit ms-drg pay significantli higher ms-drg
provid select ms-drg respect hospit
reimburs rate common procedur util integra product
calcul base nation averag base-r medicar
reimburs includ adjust rel valu weight updat
year
wound care specif note reimburs similarli
reimburs ms-drg program product util within
medic surgic treatment wound insid hospit outsid
hospit wound care product paid differ depend site
care facil seek reimburs follow program
medicar patient specif
figur bundl medicar payment surgic dress topic wound care product
btig journal advanc wound
note januari integra omnigraft primatrix product
longer paid averag sale price specif code associ
use physician offic product reimburs wholesal
acquisit cost plu said integra receiv variou rate wound
care product depend size product use case
highlight payment rate provid variou site care
treatment wound provid may util specif product
modifi seek reimburs product
ms-drgdescriptionfi base payment ratefi base payment vascular procedur pdx hemorrhag vascular procedur pdx hemorrhag vascular procedur pdx hemorrhag w/o major devic implant acut pdx mcc chemotherapi implant epilepsi major dev impl/acut complex pdx w/o endovascular intracrani procedur endovascular intracrani procedur endovascular intracrani procedur w/o shunt procedur shunt procedur shunt procedur w/o syst proc syst proc cc periph syst proc w/o disord injuri disord injuri w/o pituitari procedur pituitari procedur w/o medicar payment systemacut hospitalms-drglong-term acut hospitalltch-drgskil nurs facilityrughom agencyhhrg surgic dress hospital-bas outpati wound clinicoppsqualifi care profession officempf surgic dress
figur medicar payment rate outpati wound treatment
codedescriptionhospit outpati rateasc ratephysician facil feephysician non-facil high cost skin substitut graft trunk arm leg total wound surfac area sq cm first sq cm less wound surfac addit sq cm wound surfac area part thereof list separ addit code primari high cost skin substitut graft trunk arm leg total wound surfac area greater equal sq cm first sq cm wound surfac area bodi area infant addit sq cm wound surfac area part thereof addit bodi area infant children part thereof list separ addit code primari high cost skin substitut graft face scalp eyelid mouth neck ear orbit genitalia hand feet and/or multipl digit total wound surfac area sq cm first sq cm less wound surfac addit sq cm wound surfac area part thereof list separ addit code primari high cost skin substitut graft face scalp eyelid mouth neck ear orbit genitalia hand feet and/or multipl digit total wound surfac area greater equal sq cm first sq cm wound surfac area bodi area infant addit sq cm wound surfac area part thereof addit bodi area infant children part thereof list separ addit code primari
peter arduini presid ceo mr arduini presid ceo
integra lifesci sinc januari mr arduini join novemb
presid prior join mr arduini presid
medic deliveri baxter healthcar rate previous mr
arduini held leadership role procter gambl
consortium mdic nation italian american foundat mr arduini
receiv bachelor susquehanna univers master
northwestern univers kellogg school manag
glenn coleman cfo princip account offic mr coleman chief
financi offic princip account offic also corpor vice
presid respons intern busi prior join integra
mr coleman spent year financi manag posit
curtiss-wright corpor alcatel-luc pricewaterhousecoop llp
mr coleman receiv bachelor montclair state univers
certifi public account new jersey
robert davi corpor vice presid presid orthoped
tissu technolog mr davi join integra juli presid
global neurosurgeri busi appoint corpor vice presid
decemb prior join integra mr davi gener manag
global anaesthesia critic busi baxter healthcar
previou role mr davi held variou gener manag posit
ge healthcar area intervent therapeut cardiovascular
imag diagnost ultrasound mr davi receiv bachelor
univers delawar drexel univers master
templ univers
paul gonsalv senior vice presid chief commerci offic mr
gonsalv join integra senior vice presid enterpris sale
head corpor market mr gonsalv appoint chief
commerci offic prior integra mr gonsalv spent
year commerci busi process improv leadership role
accent health hospic well
plan mr gonsalv receiv bachelor
michael mcbreen senior vice presid presid mr
mcbreen join integra follow acquisit codman neurosurgeri
johnson johnson octob recent mr mcbreen
vice presid commerci global market codman
neurosurgeri neurovascular busi prior posit mr
mcbreen held variou leadership role johnson johnson zimmer
biomet inc mr mcbreen receiv bachelor provid colleg
reuver corpor vice presid presid specialti surgic
solut prior name presid surgic solut divis
join integra mr reuver presid omni-tract surgic
acquir integra presid advanc respiratori inc
lead sale hill-rom mr reuver current serv board
director respirtech inc
aesculap inc braun compani found tuttlingen germani
manufactur surgic instrument steril contain system
aesculap privately-own manufactur compani provid product
servic surgic disciplin includ neurosurgeri microsurgeri
ent reconstruct thorac micro-vascular cardiovascular
orthoped laparoscop gener surgeri central process
braun medic headquart bethlehem pa part braun
group compani includ braun intervent
system aesculap cap global braun group compani
employ employe countri
neuroendoscopi spine implant neurosurgeri applic power
system pneumat system neuro spine surgeri electr
system dermatom compani provid surgic instrument
retract system wound closur product includ surgic sutur
mechan sutur tissu adhes hemostat bone wax wound
closur product cardiovascular surgeri drip lubric power
system drip lubric power system oil spray oil spray cleaner
addit aesculap offer steril process solut servic
instrument steril surgic instrument equip repair
surgic instrument tray instrument basket instrument holder
asset manag servic instrument track softwar solut
becton dickinson co rate
becton dickinson co global medic technolog compani
advanc world health improv medic discoveri diagnost
deliveri care becton dickinson co provid innov solut
help advanc medic research genom enhanc diagnosi
infecti diseas cancer improv medic manag promot
infect prevent equip surgic intervent procedur
support manag diabet becton dickinson co nearli
associ across countri work close collabor
custom partner help enhanc outcom lower health care deliveri
cost increas effici improv health care safeti expand access
becton dickinson co product portfolio compet
integra said becton dickinson co possess surgic instrument
divis compet becton dickinson co mueller
snowden-penc line surgic instrument reusabl metal surgic
instrument use varieti specialti come variou
shape size along specif product line bipolar forcep
steril contain surgic headlight
johnson johnson one world largest healthcar compani oper
varieti area medic devic wound repair
ethicon depuy-synth brand product ethicon offer
varieti wound closur product skin adhes addit ethicon
offer laparoscop tool instrument also offer numer hernia
mesh product hernia closur repair within orthoped
depuy-synth brand offer product shoulder reconstruct
neurosurg care dural graft biomateri
plc headquart dublin ireland among world largest
medic technolog servic solut compani allevi pain
restor health extend life million peopl around world
employ peopl world-wide serv physician
hospit patient approxim countri
offer product neurosurg space cranial repair
product laser ablat technolog power surgic instrument shunt
similar product gener surgeri offer light retractor
hernia repair product access instrument wound closur product
one world lead medic technolog compani offer
innov product servic orthopaed medic surgic
neurotechnolog spine help improv patient hospit outcom
specif within medic surgic equip offer power tool
varieti specialti includ neurosurg applic stryker power
tool neurosurg instrument includ item bipolar forcep
bone mill comput assist surgeri high speed drill ultrason
aspir treatment varieti surgic condit
acel inc subsidiari global advanc wound care
compani leverag strength kinet concept inc systagenix
product wound vacuum dress foam dress epiderm
harvest product open abdomen manag product larg scale
wound close suffici level heal occur
johnson johnson one world largest healthcar compani oper
varieti area medic devic wound repair
ethicon depuy-synth brand product ethicon offer
varieti wound closur product skin adhes addit ethicon
offer laparoscop tool instrument also offer numer hernia
mesh product hernia closur repair within orthoped
depuy-synth brand offer product shoulder reconstruct
neurosurg care dural graft biomateri
mimedx integr develop processor market patent
protect proprietari regen biomateri product bioimplant
process human amniot membran birth tissu human
skin bone mimedx allograft product famili includ dhacm
famili amniofix epifix epiburn brand amniot fluid famili
orthoflo brand umbil famili epicord amniocord
brand placent collagen famili collafix amniofil brand
bone famili physio brand skin famili alloburn brand
amniofix epifix epiburn tissu technolog process human
amniot membran orthoflo amniot fluid deriv allograft epicord
amniocord deriv umbil cord physio uniqu bone
graft materi compris bone tissu ad carrier
alloburn skin product deriv human skin design treatment
burn collafix next brand intend commerci collagen
fiber technolog develop patent cross-link polym design
mimic natur composit structur mechan properti
musculoskelet tissu order augment repair mimedx process
human amniot membran util proprietari purion process
produc safe effect implant
organogenesi regen medicin compani focus
develop manufactur commerci product advanc
wound care surgic sport medicin market origin found
spin-off technolog develop massachusett institut
technolog organogenesi acquir nutech medic
expand compani wound care portfolio headquart canton
organogenesi employe rapidli expand
introduct new product purapli renu nucel nushield
continu focu clinic use legaci product apligraf
dermagraft
smith nephew global medic technolog busi dedic
support healthcar profession daili effort improv live
patient smith nephew offer product orthopaed reconstruct
advanc wound manag sport medicin trauma extrem
smith nephew wound care product compet across wide rang
wound care condit need includ neg pressur wound therapi
gel diabet ulcer wound dress foam dress within
orthopaed smith nephew offer varieti foot ankl upper
one world lead medic technolog compani offer
innov product servic orthopaed medic surgic
neurotechnolog spine help improv patient hospit outcom
within orthopaed stryker offer varieti product includ foot ankl
implant total ankl reconstruct orthoped trauma within
extrem offer full portfolio shoulder replac implant
biolog shoulder fractur plate separ offer product
total wrist joint replac extrem implant trauma
 global medic devic compani focus
extrem biolog compani commit deliv innov
value-ad solut improv qualiti life patient world-wide
recogn leader surgic solut upper extrem shoulder
elbow wrist hand lower extrem foot ankl biolog
market three fastest grow segment orthopaed
wright medic offer varieti product extrem procedur includ
orthobiolog foot ankl implant complet revis trauma
deform shoulder implant complet revis replac wrist
implant repair replac well
zimmer biomet global leader musculoskelet healthcar warsaw
indiana base compani design manufactur market orthopaed
reconstruct product sport medicin biolog extrem trauma
product offic base technolog spine craniomaxillofaci thorac
product dental implant relat surgic product zimmer biomet
becom largest musculoskelet focus compani follow
acquisit biomet privat held orthopaed compani time
zimmer biomet offer product extrem shoulder
replac foot ankl repair replac elbow repair biolog
neurosurg area focu
integra focu end-to-end solut neurosurg care address
broad rang condit diseas nervou
system common condit may util integra product portfolio
arterioven fistula hydrocephalu
brain arterioven malform avm brain avm result
interwoven abnorm blood vessel connect arteri vein brain
rare condit often occur fetal develop
treat surgic
brain aneurysm brain aneurysm occur blood vessel brain
bulg ruptur aneurysm lead hemorrhag stroke
life-threaten aneursym ruptur found
diagnost imag test often condit treatment
unruptur brain aneurysm may involv form craniotomi surgic
clip endovascular coil
brain tumor brain tumor growth abnorm cell brain
non-cancer benign other cancer malign
quickli grow vari wide type tumor treatment
chemotherapi target drug therapi
dural arterioven fistula similar avm dural arterioven
fistula vascular anomali form connect arteri vein
within dura matter brain condit caus neurolog
symptom bleed brain result hemorrhag
hydrocephalu hydrocephalu build-up fluid within ventricl
within brain excess fluid increas size ventricl put
pressur area brain pressur cerebrospin fluid
damag brain tissu occur often adult infant surgic
treatment hydrocephalu involv surgic insert drainag
system shunt
figur hydrocephalu brain
wound clinic area focu
classifi wound categori
wound may classifi varieti method etiolog locat
symptom depth etc within wound type variou grade system
sever wound purpos analysi classifi wound
surgic surgic wound develop incis graft donor site
excis easili close sutur stapl form skin glue
common wound present challeng heal
intend complet surgic procedur
trauma traumat wound caus outsid forc cut
punctur typic caus sever trauma traumat wound surgic
treat close surgic techniqu typic
focu wound care manag common form
diabet diabet wound commonli refer diabet ulcer begin
traumat wound patient may diabet neuropathi
feel irrit injuri wound wound
languish becom infect risk high blood glucos poor
vascular level prevent wound heal diabet patient
wound lower extrem particularli feet area
venou venou ulcer caus venou insuffici extrem
traumat wound may precursor venou ulcer blood suppli
build leg valv vein becom damag unabl
pump blood leg hypertens leg caus increas
pressur ultim lead lack oxygen diffus caus
tissu hypoxia impair wound heal venou insuffici
caus lack movement previou blood clot deep vein thrombosi
dvt varicos vein obes constip pregnanc idl
arteri arteri wound caus ischemia typic impact
lower extrem well instanc trauma preced
develop arteri wound lead pain even gangren blood
suppli cut extrem common treatment arteri wound
treatment bypass graft form revascular
pressur pressur ulcer result pressur friction combin
skin level patient immobil malnourish dehydr
develop wound boni promin heel ball
feet typic turn patient everi hour help mitig risk
weight redistribut take pressur potenti wound site
treatment wound
numer treatment option wound care often time
treatment multi-dimension requir multipl treatment beyond
immedi wound dress biolog product patient present
wound underli condit diabet hypertens obes
easili cure make wound care challeng chronic
condit said patient carri diabet hypertens
obes chronic condit wound must address time
manner wound may lead immedi acut problem
infect underli tissu skin normal serv protect
barrier bacteria
epidemiolog wound
world-wide epidemiolog burden wound signific drive
need heal closur technolog surgic wound alon requir
type intervent surgic incis occur
annual often treat minor intervent sutur
glue closur technolog chronic wound estim
patient us affect annual us healthcar system spend
upward wound relat care
clinician conduct retrospect analysi across patient
wound us wound registri analysi
provid pictur variou wound type across broad rang patient
treat outpati set may variat
make-up inpati wound rel outpati believ analysi
repres sizabl cross-sect wound type typic percentag
distribut among wound
figur distribut wound etiolog us wound registri
basic tenant wound care manag requir clinician first assess
wound infect determin foul-smel drainag
spontan bleed wound bed fragil tissu increas exud
wound increas pain cellul necrosi fasciiti lymphadenopathi
patient may also fever chill malais condit reflect
infect wound requir antibiot treatment topic antisept
avoid may interfer wound heal said surgic
debrid often perform remov necrot non-heal tissu
surgeon prepar wound bed creat environ heal
open wound bed receiv topic dress eventu
wound closur follow debrid non-debrid wound
wound irrig follow debrid moist wound dress may
appli wound dress typic maintain moist environ
allow oxygen flow wound bed limit bacteria
throughout wound heal process highli comfort dress
appli constrict oxygen wound also protect
wound outsid forc touch dress
ulcerdiabet foot ulcerchron ulcerven ulcerflap graftamputationarteri ulcer
figur variou wound dress materi medic manag wound
effect way posit wound heal surgic debrid
physician cut away use laser remov dead infect
scar tissu tissu unabl heal wound
debrid often perform surgic scalpel dead
tissu may prevent wound heal tissu mask potenti
underli abscess fluid collect well infect tissu may
hinder heal process debrid stimul heal growth factor
around edg wound prepar wound bed heal
effect way debrid wound includ mechan chemic
autolyt self-digest maggot therapi said surgic
debrid remain common surgic treatment prepar
wound debrid clinician may offer varieti solut treat
wound includ limit applic moist dress
pressur wound therapi compression/splinting/full-contact cast
advanc therapi includ biolog base skin substitut allograft
patient fail multipl week convent therapi hyperbar
oxygen therapi may use adjunct therapi
antibiot treatment antibiot use therapi must
comprehens enough take care pathogen potenti
antibiot includ cefazolin erythromycin cefoxitin cefotetan
honey base therapi medic grade honey hygroscop mean
draw moistur end dehydr bacteria given area
honey also contain glucos oxidas produc glucon acid small
amount hydrogen peroxid contact wound surfac
addit low ph honey prohibit bacteri colon bacteria
categoryexamplesdescriptionalginatealgisit comfeel curasorb kaitogel kaitostat sorbsan tegagelalgin dress made seawe extract secur use secondari coveragehydrofiberaquacel aquacel-ag versivaan absorpt textil fiber pad typic cover secondari dress hydrofib combin wound exud produc hydrophil gel debrid agentshypergel santyl accuzymevari product chemic enzymat debridementfoamlyofoam spyrosorb allevynpolyurethan foam absorpt capacityhydrocolloidcombiderm comfeel duoderm cgf extra thin granuflex tegasorbhydrocoloid dress made microgranular suspect either natur synthet polym adhes matrix form hydrogelacqusorb duoderm intrasit gel granugel normigel nugel purilon gel ky jellywat base glycerin base semiperm hydrophil polym typic secur secondari coverslow-adher dressingmepor skintact releaselow-adher dress made variou materi design remov easili without damag underli skintranspar filmopsit skintact releas tegaderm bioclusivetransper film highli conform acryl adhes filsm absorpt capac littl hydrat abil
often associ high ph level commonli use brand
medic honey medihoney formerli derma scienc own
integra dress coat medic grade honey use
instead direct honey wound
neg pressur wound therapi npwt npwt therapi system
use control neg pressur vacuum power closur devic
promot wound heal remov fluid open wound devic
attach wound seal dress tube
connect collect canist use devic shown
acceler heal variou wound
total contact cast offload pressur put wound limit
heal process significantli wound foot area
bodi help process offload wherebi pressur
appendag reduc varieti cast product help dispers
skin substitut skin substitut group wound coverag materi
assist wound closur replac function skin
transitori perman basi skin substitut classifi varieti
materi biolog synthet bi-lay tissu
engin materi also use temporari basi
class singl layer durabl skin substitut includ epiderm
dermal substitut apligraf organogenesi
class composit skin substitut skin graft tissu
classifi temporari perman synthet biolog
hyperbar oxygen therapi use hyperbar oxygen chamber
shown effect oxygen reactiv deriv hydrogen
peroxid induc angiogen respons vascular endotheli growth
factor vegf improv vessel growth promot wound heal
patient place enclos chamber breath oxygen
chamber pressur atmospher
orthoped clinic area focu
shoulder signific rang motion mobil design allow
varieti movement beyond joint bodi
shoulder connect upper arm axial skeleton compris
bone clavicl scapula scapula servic anchor mani
muscl shoulder clavicl form anterior portion
shoulder keep arm separ rest bodi assist
movement scapula also provid protect subclavian
arteri subclavian vein brachial plexu posteriorli humer head
proxim end humeru connect glenoid caviti within
shoulder prone injuri fractur clavicl
labral tear progress natur glenohumer osteoarthr
result disrupt abil rotat shoulder requir shoulder
ankl joint compris varieti structur support weight
human bodi allow move varieti direct taken
coordin ligament bone ankl joint includ talu
form socket tibia fibula bottom talu sit
calcaneu bone heel talu work like hing move
bone held togeth seri connect tissu ligament
tendon articular cartilag later ligament includ anterior
talofibular ligament atfl calcaneofibular ligament cfl
posterior talofibular ligament ptfl deltoid ligament run medial
calcaneu tibia prevent abduct three addit ligament
anterior inferior tibiofibular ligament aitfl posterior inferior tibiofibular
pitfl transvers ligament support lower end leg
form hing ankl
larg achil tendon instrument walk run jump
attach calf muscl calcaneu posterior tibial tendon attach
smaller calf muscl bottom foot support arch allow
inward foot motion
patient option come shoulder replac
primari shoulder replac involv replac arthrit joint surfac
highli polish metal ball attach stem plastic socket
manufactur offer stem metal compon variou size well
cement press-fit option
stem hemi-arthroplasti may option patient less
cartilag deterior socket healthi glenoid physician
replac head humeru stem metal ball stem
decis may made intra-op upon examin site
resurfac hemiarthroplasti replac humer head without
replac stem resurfac hemiarthroplasti younger activ
patient want avoid risk implant breakdown long period
time
lastli revers total shoulder replac peopl torn rotat
cuff shoulder arthriti convent shoulder replac result
pain limit motion revers total shoulder replac socket
metal ball switch metal ball fix socket
plastic cup fix upper end humeru revers shoulder use
deltoid muscl instead rotat cuff power posit arm
end-stag arthriti tibiotalar joint caus substanti function
impair commonli patient suffer post-traumat arthriti ankl
also experi chronic arthriti time lead need
surgic intervent total ankl arthroplasti ankl arthrodesi fusion
two primari surgic option ankl repair convent
therapi exhaust
prior prolifer variou total ankl replac implant ankl
arthrodesi gold-standard surgic treatment outcom
fusion procedur ideal nonunion rate high seen
studi patient undergo arthrodesi post-op initi
total ankl replac gain signific clinic momentum
surgeon initi implant design poor led high complic
rate current system improv outcom propon total ankl
replac believ long-term outcom equival arthrodesi
also result better motion improv gait preserv
total ankl replac procedur begin small incis
front side ankl nerv blood vessel tendon retract
joint capsul open end bone tibia fibula shape
fit prosthesi talu shape fit metal talu
compon implant place ankl test make sure
motion properli align screw ad fibula
support socket bone graft ad fibula tibia creat
fusion order prevent loosen joint
upon complet ankl non-weight-bear week allow
incis heal heal recoveri process take
common shoulder ankl replac
shoulder replac surgeri grow incid patient
remain activ longer american academi orthopaed surgeon note
increas total partial shoulder replac
studi burden musculoskelet
diseas estim annual procedur incid replac
procedur annual separ studi current trend
shoulder replac markarian et al clinic journal acta
shoulder elbow surgeri note overal incid shoulder
replac increas percentag distribut among shoulder
procedur shift hemiarthroplasti
total shoulder arthroplasti procedur distribut chang
procedur classifi total shoulder replac follow
hemiarthroplasti revers total shoulder arthroplasti
total ankl replac procedur much less common rapidli
grow reimburs rate ankl replac made
procedur econom attract physician hospit alik
studi journal orthoped zhou et al note signific
increas total ankl replac annual procedur
pale comparison larg joint replac
ankl arthrodesi procedur perform annual room
growth given prefer motion preserv ankl
replac procedur even encourag growth procedur
patient experi end-stag ankl arthriti annual seek relief
physician
incom etot y/i sale time oper incom incom tax expens net incom share net incom gross net net oper expens btig research estim compani report
revenu ecodman specialti tissu growthcodman specialti tissu growthcodman specialti tissu btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
